VTT spin-outs signal fresh momentum in Finland’s bioeconomy
- 1 day ago
- 2 min read
Finland’s bioeconomy recently gained two notable entrants, as VTT-originating startups Granarium Technologies and Elea & Lili announced funding rounds to industrialise breakthrough materials for energy storage and superabsorbent applications. The launches underscore a growing start-up space where years of public R&D are capitalising into globally scalable businesses — and hint that this is only the beginning.
Granarium Technologies is commercialising nanocellulose‑based supercapacitors that upcycle waste wood and agricultural residues into fast-response energy storage with significantly lower production costs and environmental impact than conventional solutions. As electrification and renewable integration drive structural demand for grid stabilisation, Granarium’s patented, renewable technology offers a scalable, locally producible alternative for short‑duration power needs. The company has raised over EUR 1 million, secured pilot customers and key value‑chain partners, and is preparing to launch its first pilots.
Backed by over a decade of biomaterials research at VTT, Elea & Lili is commercialising a cellulose-based alternative designed to replace fossil-based superabsorbent polymers in disposable diapers and agricultural water retention products. Their patented Cellulose Super Absorbent (CSA™) is biodegradable, microplastic‑free, compatible with existing diaper production lines, and demonstrates absorption performance comparable to conventional products. The company has raised EUR 2.5 million in seed funding led by Lifeline Ventures, and is advancing pilot production, regulatory validation, industrial partnerships, and initial launches in Europe and the U.S. The opportunity is substantial: the global superabsorbent polymers market is expected to reach USD 13.2 billion by 2030, and both consumer demand and regulation are accelerating the shift to sustainable materials.
Taken together, Granarium and Elea & Lili exemplify a new wave of Finnish deep-tech startups: IP-rich, industrially scalable and aligned with regulatory and market tailwinds. With pilot customers lined up, global partners engaged and first production steps underway, they offer promising signs that Finland’s long-term biomaterials R&D is beginning to pay off — and that this is only the beginning.
Read more:
